451 related articles for article (PubMed ID: 22442730)
1. Differential specificity of endocrine FGF19 and FGF21 to FGFR1 and FGFR4 in complex with KLB.
Yang C; Jin C; Li X; Wang F; McKeehan WL; Luo Y
PLoS One; 2012; 7(3):e33870. PubMed ID: 22442730
[TBL] [Abstract][Full Text] [Related]
2. Selective activation of FGFR4 by an FGF19 variant does not improve glucose metabolism in ob/ob mice.
Wu X; Ge H; Lemon B; Weiszmann J; Gupte J; Hawkins N; Li X; Tang J; Lindberg R; Li Y
Proc Natl Acad Sci U S A; 2009 Aug; 106(34):14379-84. PubMed ID: 19706524
[TBL] [Abstract][Full Text] [Related]
3. Molecular elements in FGF19 and FGF21 defining KLB/FGFR activity and specificity.
Agrawal A; Parlee S; Perez-Tilve D; Li P; Pan J; Mroz PA; Kruse Hansen AM; Andersen B; Finan B; Kharitonenkov A; DiMarchi RD
Mol Metab; 2018 Jul; 13():45-55. PubMed ID: 29789271
[TBL] [Abstract][Full Text] [Related]
4. Identification of a crucial amino acid responsible for the loss of specifying FGFR1-KLB affinity of the iodinated FGF21.
Luo W; Lin XM; Wang TX; Cai JL; Zeng XF; Zhu CR; Li RZ; Wang H; Wu XP
J Cell Physiol; 2019 Mar; 234(3):2500-2510. PubMed ID: 30317562
[TBL] [Abstract][Full Text] [Related]
5. Metabolic regulator betaKlotho interacts with fibroblast growth factor receptor 4 (FGFR4) to induce apoptosis and inhibit tumor cell proliferation.
Luo Y; Yang C; Lu W; Xie R; Jin C; Huang P; Wang F; McKeehan WL
J Biol Chem; 2010 Sep; 285(39):30069-78. PubMed ID: 20657013
[TBL] [Abstract][Full Text] [Related]
6. Dynamics and Distribution of Klothoβ (KLB) and fibroblast growth factor receptor-1 (FGFR1) in living cells reveal the fibroblast growth factor-21 (FGF21)-induced receptor complex.
Ming AY; Yoo E; Vorontsov EN; Altamentova SM; Kilkenny DM; Rocheleau JV
J Biol Chem; 2012 Jun; 287(24):19997-20006. PubMed ID: 22523080
[TBL] [Abstract][Full Text] [Related]
7. Control of lipid metabolism by adipocyte FGFR1-mediated adipohepatic communication during hepatic stress.
Yang C; Wang C; Ye M; Jin C; He W; Wang F; McKeehan WL; Luo Y
Nutr Metab (Lond); 2012 Oct; 9(1):94. PubMed ID: 23106963
[TBL] [Abstract][Full Text] [Related]
8. Physiology and Endocrinology Symposium: FGF21: Insights into mechanism of action from preclinical studies.
Antonellis PJ; Kharitonenkov A; Adams AC
J Anim Sci; 2014 Feb; 92(2):407-13. PubMed ID: 24398833
[TBL] [Abstract][Full Text] [Related]
9. Tissue-specific expression of betaKlotho and fibroblast growth factor (FGF) receptor isoforms determines metabolic activity of FGF19 and FGF21.
Kurosu H; Choi M; Ogawa Y; Dickson AS; Goetz R; Eliseenkova AV; Mohammadi M; Rosenblatt KP; Kliewer SA; Kuro-O M
J Biol Chem; 2007 Sep; 282(37):26687-26695. PubMed ID: 17623664
[TBL] [Abstract][Full Text] [Related]
10. Fibroblast growth factor 21, fibroblast growth factor receptor 1, and β-Klotho expression in bovine growth hormone transgenic and growth hormone receptor knockout mice.
Brooks NE; Hjortebjerg R; Henry BE; List EO; Kopchick JJ; Berryman DE
Growth Horm IGF Res; 2016; 30-31():22-30. PubMed ID: 27585733
[TBL] [Abstract][Full Text] [Related]
11. FGF21-FGFR1 Coordinates Phospholipid Homeostasis, Lipid Droplet Function, and ER Stress in Obesity.
Ye M; Lu W; Wang X; Wang C; Abbruzzese JL; Liang G; Li X; Luo Y
Endocrinology; 2016 Dec; 157(12):4754-4769. PubMed ID: 27690692
[TBL] [Abstract][Full Text] [Related]
12. The breadth of FGF21's metabolic actions are governed by FGFR1 in adipose tissue.
Adams AC; Yang C; Coskun T; Cheng CC; Gimeno RE; Luo Y; Kharitonenkov A
Mol Metab; 2012; 2(1):31-7. PubMed ID: 24024127
[TBL] [Abstract][Full Text] [Related]
13. Biological and pharmacological functions of the FGF19- and FGF21-coreceptor beta klotho.
Aaldijk AS; Verzijl CRC; Jonker JW; Struik D
Front Endocrinol (Lausanne); 2023; 14():1150222. PubMed ID: 37260446
[TBL] [Abstract][Full Text] [Related]
14. Klotho-beta and fibroblast growth factor 19 expression correlates with early recurrence of resectable hepatocellular carcinoma.
Lin ZZ; Hsu C; Jeng YM; Hu FC; Pan HW; Wu YM; Hsu HC; Hu MC; Cheng AL
Liver Int; 2019 Sep; 39(9):1682-1691. PubMed ID: 30698907
[TBL] [Abstract][Full Text] [Related]
15. FGF19-induced hepatocyte proliferation is mediated through FGFR4 activation.
Wu X; Ge H; Lemon B; Vonderfecht S; Weiszmann J; Hecht R; Gupte J; Hager T; Wang Z; Lindberg R; Li Y
J Biol Chem; 2010 Feb; 285(8):5165-70. PubMed ID: 20018895
[TBL] [Abstract][Full Text] [Related]
16. FGFR redundancy limits the efficacy of FGFR4-selective inhibitors in hepatocellular carcinoma.
Tao Z; Cui Y; Xu X; Han T
Proc Natl Acad Sci U S A; 2022 Oct; 119(40):e2208844119. PubMed ID: 36179047
[TBL] [Abstract][Full Text] [Related]
17. Fundamentals of FGF19 & FGF21 action in vitro and in vivo.
Adams AC; Coskun T; Rovira AR; Schneider MA; Raches DW; Micanovic R; Bina HA; Dunbar JD; Kharitonenkov A
PLoS One; 2012; 7(5):e38438. PubMed ID: 22675463
[TBL] [Abstract][Full Text] [Related]
18. FGF21 in obesity and cancer: New insights.
Lu W; Li X; Luo Y
Cancer Lett; 2021 Feb; 499():5-13. PubMed ID: 33264641
[TBL] [Abstract][Full Text] [Related]
19. Nutritional regulation of fibroblast growth factor 21: from macronutrients to bioactive dietary compounds.
Pérez-Martí A; Sandoval V; Marrero PF; Haro D; Relat J
Horm Mol Biol Clin Investig; 2016 Sep; 30(1):. PubMed ID: 27583468
[TBL] [Abstract][Full Text] [Related]
20. Opposite alterations in FGF21 and FGF19 levels and disturbed expression of the receptor machinery for endocrine FGFs in obese patients.
Gallego-Escuredo JM; Gómez-Ambrosi J; Catalan V; Domingo P; Giralt M; Frühbeck G; Villarroya F
Int J Obes (Lond); 2015 Jan; 39(1):121-9. PubMed ID: 24813368
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
